Gierach Marcin, Junik Roman
Department of Endocrinology and Diabetology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.
Cardiometabolic Center Gierach-Med., Bydgoszcz, Poland.
Endokrynol Pol. 2025;76(5):485-489. doi: 10.5603/ep.105209. Epub 2025 Sep 25.
Hashimoto's thyroiditis (HT) is the most common organ-specific autoimmune disorder. It is a chronic lymphocytic infiltration into the thyroid gland and is characterized by the production of anti-thyroid peroxidase antibodies (TPOAb) and anti-thyroglobulin antibodies (TgAb). HT is a polygenic disease with an incompletely defined etiopathogenesis. It affects 0.3-1.5/1000 subjects/year and is 4-10 times more frequent in women than in men (3.5-5/1000 subjects/year in women versus 0.6-1.0/1000 subjects in men).
The study group included 482 females of childbearing age (18-45 years). The group was divided into 3 subgroups: (147 - healthy individuals, 152 - hypothyreosis, 183 - HT). All patients were recruited in a 24-months period from the Cardiometabolic Center Gierach-Med in Bydgoszcz, Poland, and the Department of Endocrinology and Diabetology Collegium Medicum University of Nicolaus Copernicus in Bydgoszcz, Poland, and provided verbal consent to participate in the study.
We noticed that a lower level of ferritin was connected with a higher level of thyroid-stimulating hormone (TSH) in each of the subgroups. Additionally, we marked the correlation between ferritin and TSH and anti-thyroid antibodies (TPOAb and TgAb). There was a strong, negative correlation between TSH and ferritin level in all the study groups. Moreover, there was a weak, negative correlation between anti-TPO, anti-TG, and ferritin level in females with HT.
To sum up, we believe that hypothyroidism, especially in the course of Hashimoto's disease, leads to an increased risk of iron and ferritin deficiency and requires monitoring of these parameters.
桥本甲状腺炎(HT)是最常见的器官特异性自身免疫性疾病。它是一种甲状腺的慢性淋巴细胞浸润,其特征是产生抗甲状腺过氧化物酶抗体(TPOAb)和抗甲状腺球蛋白抗体(TgAb)。HT是一种多基因疾病,其发病机制尚未完全明确。它每年影响0.3 - 1.5/1000人,女性发病率比男性高4 - 10倍(女性为3.5 - 5/1000人/年,男性为0.6 - 1.0/1000人)。
研究组包括482名育龄女性(18 - 45岁)。该组分为3个亚组:(147名健康个体,152名甲状腺功能减退患者,183名HT患者)。所有患者均在24个月内从波兰比得哥什的Gierach - Med心脏代谢中心以及波兰比得哥什的哥白尼大学医学院内分泌与糖尿病科招募,并提供了参与研究的口头同意。
我们注意到,每个亚组中铁蛋白水平较低与促甲状腺激素(TSH)水平较高相关。此外,我们标记了铁蛋白与TSH以及抗甲状腺抗体(TPOAb和TgAb)之间的相关性。所有研究组中TSH与铁蛋白水平之间存在强烈的负相关。此外,HT女性中抗TPO、抗TG与铁蛋白水平之间存在弱的负相关。
综上所述,我们认为甲状腺功能减退,尤其是在桥本氏病过程中,会导致铁和铁蛋白缺乏风险增加,需要对这些参数进行监测。